We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+1.19%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$17.7B
AUM Growth
+$1.44B
(+8.9%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
8.95%
Top 10 Holdings %
Top 10 Hldgs %
19.92%
Holding
1,403
New
439
Increased
358
Reduced
346
Closed
241
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$403M |
| 2 |
Walt Disney
DIS
|
+$157M |
| 3 |
CELG
Celgene Corp
CELG
|
+$141M |
| 4 |
Citigroup
C
|
+$137M |
| 5 |
Starbucks
SBUX
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$244M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$178M |
| 3 |
Canadian National Railway
CNI
|
+$146M |
| 4 |
AT&T
T
|
+$139M |
| 5 |
Micron Technology
MU
|
+$134M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.11% |
| 2 | Financials | 17.79% |
| 3 | Healthcare | 17.78% |
| 4 | Consumer Staples | 7.98% |
| 5 | Consumer Discretionary | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARIA
1026
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $369K | ﹤0.01% |
+44,564
| New | +$394K |
|
1027
Commercial Metals
CMC
$8.31B
| $367K | ﹤0.01% |
+22,800
| New | +$372K |
|
1028
VEON
VEON
$3.95B
| $366K | ﹤0.01% |
+2,948
| New | +$418K |
|
1029
Arthur J. Gallagher & Co
AJG
$63.6B
| $364K | ﹤0.01% |
+7,700
| New | +$371K |
|
|
BMTC
1030
DELISTED
Bryn Mawr Bank Corp
BMTC
| $364K | ﹤0.01% |
+12,059
| New | +$364K |
|
|
MDSO
1031
DELISTED
Medidata Solutions, Inc.
MDSO
| $364K | ﹤0.01% |
+6,700
| New | +$360K |
|
1032
Argan
AGX
$8.37B
| $362K | ﹤0.01% |
+8,965
| New | +$321K |
|
1033
Citizens
CIA
$192M
| $353K | ﹤0.01% |
47,318
+15,000
| +46% | +$94K |
|
1034
Liberty Media Series A
FWONA
$23.6B
| $353K | ﹤0.01% |
14,576
-1,814
| -11% | -$46.8K |
|
|
UNTD
1035
DELISTED
UNITED ONLINE INC COM NEW
UNTD
| $349K | ﹤0.01% |
+22,300
| New | +$369K |
|
|
PBPB
1036
DELISTED
Potbelly
PBPB
| $348K | ﹤0.01% |
+28,400
| New | +$399K |
|
1037
Haemonetics
HAE
$4B
| $343K | ﹤0.01% |
+8,300
| New | +$350K |
|
|
TPC
1038
Tutor Perini Cor
TPC
$5.21B
| $343K | ﹤0.01% |
15,888
-116,594
| -88% | -$2.66M |
|
|
PBY
1039
DELISTED
PEP BOYS MANNY MOE& JACK
PBY
| $339K | ﹤0.01% |
+27,600
| New | +$280K |
|
1040
Simmons First National
SFNC
$3.39B
| $337K | ﹤0.01% |
+14,428
| New | +$321K |
|
1041
Coca-Cola Consolidated
COKE
$12.8B
| $334K | ﹤0.01% |
+22,110
| New | +$266K |
|
|
SNP
1042
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $334K | ﹤0.01% |
+3,900
| New | +$343K |
|
1043
Wabtec
WAB
$49.3B
| $330K | ﹤0.01% |
+3,500
| New | +$344K |
|
1044
Arbor Realty Trust
ABR
$998M
| $325K | ﹤0.01% |
+48,100
| New | +$334K |
|
1045
Mohawk Industries
MHK
$9.22B
| $325K | ﹤0.01% |
+1,700
| New | +$314K |
|
|
YHOO
1046
DELISTED
Yahoo Inc
YHOO
| $324K | ﹤0.01% |
8,244
-625,205
| -99% | -$26.9M |
|
1047
Deluxe
DLX
$1.15B
| $322K | ﹤0.01% |
5,200
-44,649
| -90% | -$2.93M |
|
1048
Standard Motor Products
SMP
$911M
| $321K | ﹤0.01% |
9,142
-58,572
| -86% | -$2.23M |
|
1049
Kadant
KAI
$3.99B
| $319K | ﹤0.01% |
6,749
-2,621
| -28% | -$131K |
|
1050
First Busey Corp
BUSE
$2.56B
| $317K | ﹤0.01% |
16,066
| – | – |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2015 Portfolio in Review
As of Q2 2015, Arrowstreet Capital held 1,403 positions worth $17.7B, up 8.9% from $16.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Arrowstreet Capital deployed $1.58B of net new capital in Q2 2015, opening 439 new positions and adding to 358 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,922,584 shares worth $114M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Union Pacific, an estimated $244M trimmed.
- Arrowstreet Capital's largest Q2 2015 buy was Teva Pharmaceuticals: 1,922,584 shares worth $114M.
- Arrowstreet Capital added most to Apple in Q2 2015, an estimated $403M increase.
- Arrowstreet Capital's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $244M.
- Arrowstreet Capital fully exited Canadian National Railway in Q2 2015, selling an estimated $146M.
- Arrowstreet Capital's ten largest holdings make up 20% of its $17.7B portfolio in Q2 2015.
- Arrowstreet Capital opened 439 new positions and closed 241 in Q2 2015.
- Arrowstreet Capital's portfolio value rose 8.9% quarter-over-quarter to $17.7B.
Based on Arrowstreet Capital's 13F filing for Q2 2015, filed 13 Aug 2015.